VTN
Vitronectin
Also known as: VN, VTNC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04004
- Gene
- VTN
- Ensembl
- ENSG00000109072
- Chromosome
- 17
- Canonical length
- 478 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene functions in part as an adhesive glycoprotein. Differential expression of this protein can promote either cell adhesion or migration as it links cells to the extracellular matrix through a variety of ligands. These ligands include integrins, plasminogen activator inhibitor-1, and urokinase plasminogen activator receptor. This secreted protein can be present in the plasma as a monomer or dimer and forms a multimer in the extracellular matrix of several tissues. This protein also inhibits the membrane-damaging effect of the terminal cytolytic complement pathway and binds to several serpin serine protease inhibitors. This protein can also promote extracellular matrix degradation and thus plays a role in tumorigenesis. It is involved in a variety of other biological processes such as the regulation of the coagulation pathway, wound healing, and tissue remodeling. The heparin-binding domain of this protein give it anti-microbial properties. It is also a lipid binding protein that forms a principal component of high density lipoprotein. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
478 residues, UniProt reviewed canonical sequence.
>P04004|VTN
1 MAPLRPLLIL ALLAWVALAD QESCKGRCTE GFNVDKKCQC DELCSYYQSC CTDYTAECKP
61 QVTRGDVFTM PEDEYTVYDD GEEKNNATVH EQVGGPSLTS DLQAQSKGNP EQTPVLKPEE
121 EAPAPEVGAS KPEGIDSRPE TLHPGRPQPP AEEELCSGKP FDAFTDLKNG SLFAFRGQYC
181 YELDEKAVRP GYPKLIRDVW GIEGPIDAAF TRINCQGKTY LFKGSQYWRF EDGVLDPDYP
241 RNISDGFDGI PDNVDAALAL PAHSYSGRER VYFFKGKQYW EYQFQHQPSQ EECEGSSLSA
301 VFEHFAMMQR DSWEDIFELL FWGRTSAGTR QPQFISRDWH GVPGQVDAAM AGRIYISGMA
361 PRPSLAKKQR FRHRNRKGYR SQRGHSRGRN QNSRRPSRAT WLSLFSSEES NLGANNYDDY
421 RMDWLVPATC EPIQSVFFFS GDKYYRVNLR TRRVDTVDPP YPRSIAQYWL GCPAPGHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VTN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 5,645 nTPM
Expression across tissuesHPA
Tissue
- liver: 5,645 nTPM
- adrenal gland: 124 nTPM
- gallbladder: 58 nTPM
- heart muscle: 50 nTPM
- retina: 44 nTPM
- placenta: 38 nTPM
Single-cell type
- hepatocytes: 2,942 nCPM
- cholangiocytes: 899 nCPM
- kupffer cells: 32 nCPM
- pancreatic duct cells: 30 nCPM
- sertoli cells: 25 nCPM
- cone photoreceptor cells: 25 nCPM
Immune cell
- naive CD8 T-cell: 0.3 nTPM
- gdT-cell: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
Brain region
- midbrain: 14 nTPM
- cerebellum: 14 nTPM
- cerebral cortex: 9 nTPM
- basal ganglia: 8.1 nTPM
- hypothalamus: 8.1 nTPM
- hippocampal formation: 7.6 nTPM
ReferencesPubMed · IEDB
Publications for VTN from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Expression of two novel recombinant proteins from aortic adventitia (kappafibs) sharing amino acid sequences with cytomegalovirus.
1997 · J Surg Res · RCR 0.5 · 16 citations - Molecular cloning of the complementary DNA for an additional member of the family of aortic aneurysm antigenic proteins.
1997 · J Vasc Surg · RCR 0.4 · 17 citations - Immunoregulatory role of gamma delta T cells.
1991 · Ann N Y Acad Sci · RCR 0.1 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell adhesion mediated by integrin
- cell migration
- cell-matrix adhesion
- endodermal cell differentiation
- extracellular matrix organization
- immune response
- integrin-mediated signaling pathway
- liver regeneration
- negative regulation of blood coagulation
- negative regulation of fibrinolysis
- negative regulation of proteolysis
- oligodendrocyte differentiation
- positive regulation of cell-substrate adhesion
- positive regulation of integrin-mediated signaling pathway
- positive regulation of receptor-mediated endocytosis
- positive regulation of smooth muscle cell migration
- positive regulation of vascular endothelial growth factor receptor signaling pathway
- positive regulation of vascular endothelial growth factor signaling pathway
- positive regulation of wound healing
- protein polymerization
- regulation of cell adhesion
- smooth muscle cell-matrix adhesion
Molecular functions
- collagen binding
- extracellular matrix binding
- extracellular matrix structural constituent
- heparin binding
- identical protein binding
- integrin binding
- polysaccharide binding
- scavenger receptor activity
Cellular components
- alphav-beta3 integrin-vitronectin complex
- basement membrane
- blood microparticle
- endoplasmic reticulum
- extracellular exosome
- extracellular matrix
- extracellular region
- extracellular space
- Golgi lumen
- peptidase inhibitor complex
- protein complex involved in cell-matrix adhesion
- rough endoplasmic reticulum lumen
- symbiont-containing vacuole
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VTN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VTN as an antibody target. Whether an autoantibody or antibody against VTN could matter depends on whether native VTN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VTN is annotated as secreted, so native VTN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label VTN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...